|
Recommended Books on Pneumonia
Variability in Geometry and Imperfections of Surface Ship Structural Scantlings This is a NAVAL SURFACE WARFARE CENTER CARDEROCK DIV BETHESDA MD report procured by the Pentagon and made available for public release. It has been reproduced in the best form available to the Pentagon. It is not spiral-bound, but rather assembled with Velobinding in a soft, white linen cover. The Storming Media report number is A351033. The abstract provided by the Pentagon follows: Random behavior of strength variables of a structure can cause the strength of the structure to vary beyond acceptable levels. The design strength is based on nominal values for variables such as yield stress of the material, plate thickness, modulus of elasticity, and so forth. The actual values of these variables are often different from the nominal, or design values. Understanding the randomness of the basic strength variable behavior allows the designer to account for this in the design strength of the structure. The basic structural strength variables may be classified into material variables, such as yield strength and ultimate strength, and geometry or construction variables, such as plate thickness and stiffener height. The objective of this study is to quantify the randomness or uncertainty found in the geometric variables used in the analysis and design of surface ship structures. The bulk of the data used in this study are for U.S. Navy ships. Additional data is provided for U.S. Coast Guard and commercial vessels. The results of this study can be used in the development of reliability based design criteria, tolerance limits, and the assessment of uncertainty in strength predictions.
Community-Acquired Pneumonia: A Plan for Implementing National Guidelines at the Local Hospital Level ...the intent of this book is to outline a plan for imple- mentation of a cap practice guideline at the local hospital level
Nosocomial Pneumonia (Lung Biology in Health and Disease) This timely reference provides the latest information on the diagnosis, treatment, and prevention of nosocomial pneumonia, including risk factors, diagnostic tests used to make the definitive diagnosis, likely pathogens, and the most effective treatment options. Contains guidelines for the prevention of nosocomial pneumonia-emphasizing selected high-risk pathogens! Written by leading authorities in the field, Nosocomial Pneumonia · compares bacterial, mycobacterial, viral, and fungal pneumonias and defines hospital-acquired pneumonias through aspiration and contiguous spread, gastric colonization and sinusitis, infection rates, and rates of morbidity and mortality · identifies patients with key risk factors such as age, underlying disease, severe illness and/or immunosuppression, diabetes, and smoking · discusses how to reduce or eliminate device- and procedure-related risk factors, including nasogastric tubes, endotracheal tubes, mechanical ventilation, inhalation anesthesia, thoraco-abdominal surgery, and others · examines antimicrobial therapy, including penicillin, ampicillin, amox-clavulanate, cefaclor, cefurox, ceftriaxone, erythromycin, clarithromycin, azithromycin, chloramphenicol, doxycycline, ofloxacin, levofloxacin, vancomycin, and other nonantimicrobial therapies · clarifies the role of all health care workers in the prevention of nosocomial pneumonia, including the use of gloves, gowns, masks, isolation precautions, and proper disinfection and sterilization of medical equipment · highlights unique settings and populations where control and prevention of nosocomial acquired pneumonia is essential, including operating rooms; immunocompromised patients, including neonates and pediatric patients; and ambulatory and nonambulatory patients Nosocomial Pneumonia is a required reference for pulmonologists, physiologists, infectious disease specialists, intensivists, critical care physicians, hospital epidemiologists, clinical microbiologists, anesthesiologists, respiratory therapists, infection control professionals, nurses, pediatricians, surgeons, internists, family physicians, hospital administrators, and medical students.
21st Century Collection Centers for Disease Control (CDC) Emerging Infectious Diseases (EID) ¿ Guide to SARS (Severe Acute Respiratory Syndrome) and Atypical Pneumonia, Influenza (Flu), Antiviral Drugs, Respiratory and Lung Diseases, Infection Control, C This up-to-date and comprehensive set of two CD-ROMs provides a superb collection of official Federal government documents on the newest emerging threat to world health, Severe Acute Respiratory Syndrome. SARS, first discovered in early 2003 and frequently presenting as atypical pneumonia, has been described in the Washington Post as "the first life-threatening new disease in emerge in decades that can be spread from one person to another by casual contact." SARS is believed to be caused by a new type of coronavirus. It poses unique and potentially serious problems for the citizens of all nations.
Every aspect of SARS is thoroughly covered, along with related diseases and public health threats - including influenza and influenza drugs and vaccines, antiviral drugs including ribavirin (used by some physicians in Hong Kong to treat SARS patients), respiratory and lung diseases, and infection control procedures including quarantine, disinfection, hand hygiene, and respirator mask fitting. There is extensive material from the World Health Organization (WHO) about the SARS outbreak. Other topics covered: * Pleconaril For Treatment Of Common Cold - FDA Antiviral Drugs Advisory Committee Meeting 2002 * FDA Antiviral Drug Advisory Meetings (transcripts from 1996 to 2002) As a bonus, we've included full copies of the latest issues of the CDC peer-reviewed journal, EMERGING INFECTIOUS DISEASES, from January 2001 through MAY 2003. Also in this collection of CDC documents: the famous "Pinkbook" - EPIDEMIOLOGY AND PREVENTION OF VACCINE-PREVENTABLE DISEASES - including influenza - and CDC material regarding the careful use of antibiotics to prevent the continued development of dangerous antimicrobial resistance. Material from every relevant federal agency is included: Centers for Disease Control (CDC) Food and Drug Administration (FDA) Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) Environmental Protection Agency (EPA) Occupational Health and Safety Administration (OSHA) Congressional (House and Senate) Testimony In addition to the text, we've included the computer video files (in Real Media format) of two outstanding CDC public health training conferences - "Preventing the Spread of AIDS" and "Increasing Clinician Preparedness for SARS." These superb television presentations are perfect for learning the latest on SARS. The two discs contain over one gigabyte of material. There is no other reference that is as fast, convenient, and portable - everything you need to know, from the federal sources you trust. By using weblinks built into the documents reproduced on the CD-ROM, you can quickly and easily check for the latest clinical updates directly from the government. In all, the disc has over 39,000 pages reproduced using Adobe Acrobat PDF software - allowing direct viewing on Windows and Apple Macintosh systems. Reader software is included on the CD. Our CD-ROMs are designed to provide a convenient user-friendly reference work, utilizing the benefits of the Acrobat format to uniformly present thousands of pages that can be rapidly reviewed or printed without untold hours of tedious searching and downloading. Vast archives of important public domain government information that might otherwise remain inaccessible are available for instant review no matter where you are. (Information on this CD-ROM set is not a substitute for professional medical advice; of course, readers are urged to consult with a professional health care provider for any suspected illness.) This book-on-a-disc set makes a great reference work and educational tool for medical professionals, physicians, and patients and their families.
The Role Of U.S. Maritime Policy In Strategic Sealift This is a NAVAL POSTGRADUATE SCHOOL MONTEREY CA report procured by the Pentagon and made available for public release. It has been reproduced in the best form available to the Pentagon. It is not spiral-bound, but rather assembled with Velobinding in a soft, white linen cover. The Storming Media report number is A196773. The abstract provided by the Pentagon follows: Strategic sealift is essential to the Department of Defense for it to carry out its national security mission. Surge sealift is provided primarily by DoD's organic fleet. Sustainment sealift is accomplished through chartering commercial ships. U.S. maritime policy places the primary requirement for sustainment sealift on the U.S. maritime industry. Policies dating to the 1920s attempt to ensure an adequate number of ships by providing operating subsidies and cargo preference. Despite these policies, the size of the U.S. commercial fleet has decline& DoD uses foreign flag ships to meet its needs when U.S.- flagged vessels are not available. Foreign flag ship use is significant and presents risk to the conduct of military operations. The world maritime industry has undergone significant change. The rise of flags of convenience and open registries has altered the industry. This thesis reviews U.S. maritime policy, DoD's requirement for sealift and options for obtaining sealift. It identifies and explores the nature of the risk related to strategic sealift facing the DoD as it enters the 21st century and suggests that the risk associated with the use of foreign flag vessels is low.
Contemporary Diagnosis and Management of Community-Acquired Pneumonia Community-acquired pneumonia is a growing problem, particularly among the elderly in hospitals and nursing homes. This practical reference outlines the latest antibiotic regimens to combat this life-threatening condition.
Diagnosis and Management of Pneumonia and Other Respiratory Infections Treatment of community-acquired pneumonia and hospital-acquired pneumonia, when to hospitalize a patient, methods for identifying low-risk CAP patients, switch and step-down therapy, approach to nonresolving pneumonia, management of parapneumonic effusions, empyema, and chronic bronchitis are discussed. The various antimicrobial agents are reviewed in detail with suggested treatment regimens.
A Joint Campaign Analysis Approach to Antisubmarine Warfare Using a Circulation. Model Template This is a NAVAL POSTGRADUATE SCHOOL MONTEREY CA report procured by the Pentagon and made available for public release. It has been reproduced in the best form available to the Pentagon. It is not spiral-bound, but rather assembled with Velobinding in a soft, white linen cover. The Storming Media report number is A319223. The abstract provided by the Pentagon follows: To enhance insight into a war at sea, a general, aggregated and highly flexible model of the ASW campaign is offered. This thesis provides a simple and usable circulation model template. The generality and simplicity of the model allows for 'jointization' of an ASW campaign by allowing the user to utilize other resources to define the force mix. The model is designed, first and foremost, to examine the change in the marginal effectiveness of friendly ASW forces due to changes in force level, mix, effectiveness, and employment strategies. The model is keyed to the interaction of a threat submarine with friendly ASW forces and merchant or military shipping. Specific features of the model provide for four unique attack regimes. The in port and operational regimes control friendly attacks on a daily basis while the outbound and inbound regimes control barriers by events. The campaign model is a deliverable product programmed using Borland(registered) Delphi for use in Microsoft Windows.
The Official Patient's Sourcebook on Mycoplasma Pneumonia: A Revised and Updated Directory for the Internet Age This sourcebook has been created for patients who have decided to make education and Internet-based research an integral part of the treatment process. Although it gives information useful to doctors, caregivers and other health professionals, it also tells patients where and how to look for information covering virtually all topics related to mycoplasma pneumonia, from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on mycoplasma pneumonia. Following an introductory chapter, the sourcebook is organized into three parts. PART I: THE ESSENTIALS; Chapter 1. The Essentials on Mycoplasma Pneumonia: Guidelines; Chapter 2. Seeking Guidance; PART II: ADDITIONAL RESOURCES AND ADVANCED MATERIAL; Chapter 3. Studies on Mycoplasma Pneumonia; Chapter 4. Patents on Mycoplasma Pneumonia; Chapter 5. Books on Mycoplasma Pneumonia; Chapter 6. Multimedia on Mycoplasma Pneumonia; Chapter 7. Physician Guidelines and Databases; PART III. APPENDICES; Appendix A. Researching Your Medications; Appendix B. Researching Alternative Medicine; Appendix C. Finding Medical Libraries; Appendix D. Your Rights and Insurance; ONLINE GLOSSARIES; MYCOPLASMA PNEUMONIA GLOSSARY; INDEX. Related topics include: Atypical pneumonia, Cold agglutinin-positive pneumonia, Eaton agent pneumonia, Primary atypical pneumonia (PAP), Walking pneumonia.This sourcebook has been created for patients who have decided to make education and Internet-based research an integral part of the treatment process. Although it gives information useful to doctors, caregivers and other health professionals, it also tells patients where and how to look for information covering virtually all topics related to mycoplasma pneumonia, from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on mycoplasma pneumonia. Following an introductory chapter, the sourcebook is organized into three parts. PART I: THE ESSENTIALS; Chapter 1. The Essentials on Mycoplasma Pneumonia: Guidelines; Chapter 2. Seeking Guidance; PART II: ADDITIONAL RESOURCES AND ADVANCED MATERIAL; Chapter 3. Studies on Mycoplasma Pneumonia; Chapter 4. Patents on Mycoplasma Pneumonia; Chapter 5. Books on Mycoplasma Pneumonia; Chapter 6. Multimedia on Mycoplasma Pneumonia; Chapter 7. Physician Guidelines and Databases; PART III. APPENDICES; Appendix A. Researching Your Medications; Appendix B. Researching Alternative Medicine; Appendix C. Finding Medical Libraries; Appendix D. Your Rights and Insurance; ONLINE GLOSSARIES; MYCOPLASMA PNEUMONIA GLOSSARY; INDEX. Related topics include: Atypical pneumonia, Cold agglutinin-positive pneumonia, Eaton agent pneumonia, Primary atypical pneumonia (PAP), Walking pneumonia.
Infectious Diseases in Critical Care
Infections and their complications are a very important clinical area in the intensive care unit setting. Community-acquired infections and nosocomial infections both contribute to the high level of disease acquisition common among critically ill patients. The accurate diagnosis of nosocomial infections and the provision of appropriate therapies, including antimicrobial therapy effective against the identified agents of infection, have been shown to be important determinants of patient outcome. Critical care practitioners are in a unique position in dealing with infectious diseases. They are often the initial providers of care to seriously ill patients with infections. Additionally, they have a responsibility to ensure that nosocomial infections are prevented and that antimicrobial resistance is minimized by prudently employing antibiotic agents. It is the editors' hope that this book will provide clinicians practicing in the intensive care unit with a reference to help guide their care of infected patients. To that end they have brought together a group of international authors to address important topics related to infectious diseases for the critical care practitioner.
© 2004-2008 Pneumonia Research Today. All Rights Reserved.
|
|
